8:45 am -
9:45 am
|
South Carolina Pharmacy Law Update
|
Kayce Shealy, PharmD, BCPS, CDCES;
Dean for Academic Affairs and Professor of Pharmacy Practice, Presbyterian College School of Pharmacy
|
|
10:00 am - 11:00 am |
Updates on Oral Cancer Medications
|
L. Michelle Cakley, PharmD;
Oncology Pharmacist, South Carolina Oncology Associates
|
|
11:15 am - 12:45 pm |
Unlocking Potential: Leading with Empathy and Impact
|
Julie M. Sease, PharmD, FCCP, BCPS, CDCES, BCACP;
Senior Associate Dean and Clinical Professor,
USC College of Pharmacy
|
|
2:00 pm -
3:00 pm
|
Top 10 Infectious Diseases Stories: A look back at 2024
|
P. Brandon Bookstaver, PharmD, BCIDP, FCCP, FIDSA;
Professor & Director of Residency & Fellowship Training,
USC College of Pharmacy;
Infectious Diseases Pharmacist, Prisma Health Richland;
ID PGY2 & Clinical Fellowship Director, Prisma Health – USC;
Academic Fellowship Director, USC College of Pharmacy
|
|
3:15 pm -
4:45 pm
|
Medications for Opioid Use Disorder:
The Pharmacists’ Role and Key Considerations
|
Kaileigh Yen, PharmD;
Practice Advancement Fellow,
UNC Eshelman School of Pharmacy
|
8:45 am - 9:45 am |
|
Rare Remedies: Navigating the Approval and Use of Orphan Drugs in Pharmacy Practice
|
Betsy Blake PharmD, BCPS, FNAP;
Clinical Associate Professor and Director of
Interprofessional Education
USC College of Pharmacy |
10:00 am - 11:00 am |
Immunization Update 2025
|
Patricia H. Fabel, PharmD, BCPS, FAPhA;
Clinical Associate Professor, USC College of Pharmacy
|
|
11:00 am - 12:00 pm |
|
Double Duty: Unveiling the Benefits of GLP-1 Receptor Agonists
|
Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM;
Clinical Professor and Director of Pharmacy Education, USC College of Pharmacy |
1:00 pm - 2:00 pm |
A Guide to Medication Treatment of Depression and Anxiety Disorders
|
Jordan C. Haygood, PharmD, BCPP;
Clinical Pharmacy Specialist - Psychiatry, MUSC
|
|
2:15 pm - 3:15 pm |
Balancing Comfort and Safety in
Post-Op Pain Management
|
Lauren Linder, PharmD, BCPP;
Senior Research Associate, Co-Director &
Clinical Pharmacy Consultant,
SCORxE Academic Detailing Service,
Division of General Internal Medicine,
Geriatrics, and Palliative, MUSC
|
|
3:30 pm - 4:30 pm |
Primary Care New Drug Update – 2025
|
Kelly Jones, PharmD;
Director of Outpatient Pharmacotherapy Education,
McLeod Family Medicine Program, McLeod Health
|
|
Hours* | Pharmacists** | Pharmacy Technicians |
All programming
(Saturdays, February 1
AND
March 15)
|
12 live
|
$170*L | $110*L |
- Active PEEP Preceptors: You will receive communication via email regarding discounted registration!
- USC College of Pharmacy Alumni: Prior to registering, please check your email and/or mail for information from the COP on discounted registration!
- * - For those who choose to attend in-person, fees include a continential breakfast and lunch
- L- Please note that fees will appear as “Learning Express” on your credit card statement
- All participants must have an electronic device with a stable internet connection and working video/audio capabilities in order to participate.
- All activities will be held via Zoom. Participants must download the latest version of Zoom and register for Zoom using their first and last name (to allow for registration to be verified upon admittance to the room).
- Full Zoom system requirements, if needed, may be found here for Windows, macOS, and Linus or here for iOS, iPadOS, and Android.
- *If you are unfamiliar with Zoom, uncomfortable with the technology, or do not have the technology needed, please contact us at CE@cop.sc.edu so we can discuss accommodations!*
- Please visit our website to view our policy on privacy and confidentiality of your information.
-
In order to have CPE Credit transmitted to the NABP CPE Monitor, participants must:
- Be registered for the activity via this site
- If in-person, sign-in at registration table
- If Virtual, participants must join the Zoom meeting via a computer, tablet, or mobile device which will allow for viewing of video and listening to audio.
- All participants should log into Zoom separately to allow for verification of attendance. Please message us if you and another registrant will be viewing together.
- Attend the session in its entirety (participants who walk-in/log-in late or leave the session early will not be eligible for credit).
- Actively participate in all polling questions, discussions, active learning, and learning assessments.
- Complete the electronic evaluation within 30 days following completion of the activity. Any credit claimed greater than 60 days from the date of the program will automatically be rejected by the CPE Monitor.
Date: Feb 1, 2025 08:00 AM - Mar 15, 2025 04:30 PM
CE Hours
CE Units
Registration closes on Jan 31, 2025 10:00 PM
Activity Type
- Knowledge-Based and Application-Based
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Please choose a Fee Type from the Drop Down Menu Below:
I am a
|
- Explain the role and responsibilities of the Board of Pharmacy in regulating pharmacy practice and ensuring compliance
- Identify recent changes to laws and policies that impact the roles and duties of pharmacy personnel
- Discuss the practical implications of updated pharmacy regulations on workflow and patient safety
Speaker(s)/Author(s)
Kayce M. Shealy, PharmD, BCPS, CDCES
|
Activity Number
0062-0000-25-007-L03-P/TCE Hours
- Recognize oral cancer medication treatment cycles
- Identify common drug-drug interactions with oral cancer medications
- Describe best practices for managing adverse events associated with oral cancer medications
- Discuss interventions for improving adherence to oral cancer medications
- Recognize oral cancer medication treatment cycles
- Identify potential drug interactions with oral cancer medications
- Discuss common adverse events associated with oral cancer medications
- Discuss interventions for improving adherence to oral cancer medications
Speaker(s)/Author(s)
L. Michelle Cakley, PharmD
|
Activity Number
0062-0000-25-008-L01-P/TCE Hours
- Determine practical strategies for using emotional intelligence to improve teamwork
- Apply emotional intelligence concepts to improve teamwork in a real-world environment
- Identify key managerial actions that foster psychological safety in the workplace
- Apply best practices for conducting crucial conversations in real-world scenarios
Speaker(s)/Author(s)
Julie Sease, PharmD, FCCP, BCPS, CDCES, BCACP
|
Activity Number
0062-0000-25-009-L99-P/TCE Hours
- Summarize newly approved antimicrobials or those with expanded indications in 2024
- Recall key peer-reviewed evidence impacting infectious diseases patient care in 2024
- Identify important updates in infectious diseases clinical practice guidelines in 2024
Speaker(s)/Author(s)
P. Brandon Bookstaver, PharmD, FCCP, BCIDP
|
Activity Number
0062-0000-25-010-L01-P/TCE Hours
- Summarize the medications for opioid use disorder (MOUD), including their indication, dosing, side effects, and clinical pearls
- Evaluate the pharmacists’ role in MOUD in various healthcare settings
- Differentiate between state and federal regulations surrounding the use and dispensing of MOUD
- Identify barriers to buprenorphine access for pharmacies and patients
- Recommend opioid overdose prevention strategies and resources to support safe and effective care for patients with OUD
- Summarize the medications for opioid use disorder (MOUD), including their indication, dosing, side effects, and clinical pearls
- Evaluate the technicians’ role in MOUD in various healthcare settings
- Describe state and federal regulations surrounding the use and dispensing of MOUD
- Identify barriers to buprenorphine access for pharmacies and patients
- Describe opioid overdose prevention strategies and available resources to assist in patient care
Speaker(s)/Author(s)
Kaileigh Yen, PharmD
|
Activity Number
0062-0000-25-011-L08-P/TCE Hours
- Explain the regulatory process for medications used in rare disorders
- Identify challenges in developing and approving medications for rare disorders
- Recognize commonly prescribed medications for rare disorders and their indications
- Summarize the role of the pharmacist with medications for rare disorders
Speaker(s)/Author(s)
Betsy Blake, PharmD, BCPS, FNAP
|
Activity Number
0062-0000-25-012-L01-P/TCE Hours
- Apply updates from the national immunization recommendations to patient cases
- Recall vaccine safety and efficacy data
- Compare and contrast newly approved vaccine products
- Define proper vaccine administration techniques
- Explain the technician's role in providing immunizations
- Summarize updates to national immunization recommendations
- List newly approved vaccine products
- Review proper vaccine storage and handling
Speaker(s)/Author(s)
Patricia Fabel, PharmD, BCPS
|
Activity Number
0062-0000-25-013-L06-P/TCE Hours
- Describe the mechanism of action for glucagon-like peptide-1 (GLP-1) receptor agonists in diabetes and obesity
- Identify the additional benefits of GLP-1 receptor agonists beyond diabetes and obesity management, including mortality and morbidity outcomes
- Develop a person-centered plan incorporating GLP-1 receptor agonists with appropriate follow-up to monitor efficacy and safety
Speaker(s)/Author(s)
Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM
|
Activity Number
0062-0000-25-014-L01-P/TCE Hours
- Review the pharmacology of medications used to treat depressive and anxiety disorders
- Summarize new treatment options for depressive and/or anxiety disorders
- Recommend an evidence-based medication regimen for patients with depressive and/or anxiety disorders
- Describe common medications used to treat depressive and anxiety disorders
- Identify new treatment options for depressive and/or anxiety disorders
- Analyze medication orders for patients with depressive and/or anxiety disorders to ensure accuracy
Speaker(s)/Author(s)
Jordan Cooler Haygood, PharmD, BCPP
|
Activity Number
0062-0000-25-015-L01-P/TCE Hours
- Describe pre-operative screening methods of patients for preventing misuse and diversion of opioids
- Explain strategies for setting patient expectations about post-operative pain that promote conservative opioid use and enhance patient satisfaction
- Review special pain management considerations for patients on chronic opioids, including patients on medications for OUD who undergo surgery
- Formulate a surgery pain management plan for a patient on chronic opioids
- Describe pre-operative screening methods of patients for preventing misuse and diversion of opioids
- Explain strategies for setting patient expectations about post-operative pain that promote conservative opioid use and enhance patient satisfaction
- Review special pain management considerations for patients on chronic opioids, including patients on medications for OUD who undergo surgery
- Analyze medication orders for a surgery pain management plan in patients on chronic opioids
Speaker(s)/Author(s)
Lauren Linder Wier, PharmD, BCPS, BCPP
|
Activity Number
0062-0000-25-016-L08-P/TCE Hours
- Identify new therapeutic agents recently marketed and their appropriate use
- Describe the indications, key adverse events, and precautions associated with each new therapeutic agent
- Compare and contrast new medications to others within similar therapeutic categories
- Discuss important drug interactions and pharmacokinetic parameters that are clinically relevant
- Identify new therapeutic agents recently marketed and their appropriate use
- Describe the indications, key adverse events, and precautions associated with each new therapeutic agent
- Compare and contrast new medications to others within similar therapeutic categories
- List important drug interactions associated with the new medications
Speaker(s)/Author(s)
Kelly Jones, PharmD
|